CD21 signaling via C3 regulates Purkinje cell protein 4 expression

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1488-1493

  Jacobson, Amanda C ^a   Weis, Janis J ^a   Weis, John H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; B cells; C3; Complement; Cr2

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CALCIUM TRANSPORT; CELL MATURATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CROSS LINKING; FEMALE; GENE; GENE EXPRESSION PROFILING; MOUSE; NONHUMAN; PCP4 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; COMPLEMENT C3; CROSS-LINKING REAGENTS; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCR; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION; SPLEEN;

ANIMALIA; MURINAE; MUS;

EID: 62549139163     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.12.030     Document Type: Article

References (33)

1. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., and Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (1996) 251-262
2. Barrington R.A., Pozdnyakova O., Zafari M.R., Benjamin C.D., and Carroll M.C. B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J. Exp. Med. 196 (2002) 1189-1199
3. Buhl A.M., Pleiman C.M., Rickert R.C., and Cambier J.C. Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J. Exp. Med. 186 (1997) 1897-1910
4. Cahalan M.D., Wulff H., and Chandy K.G. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21 (2001) 235-252
5. Carter R.H., Spycher M.O., Ng Y.C., Hoffman R., and Fearon D.T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141 (1988) 457-463
6. Chakravarty L., Zabel M.D., Weis J.J., and Weis J.H. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14 (2002) 139-146
7. Cherukuri A., Cheng P.C., and Pierce S.K. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167 (2001) 163-172
8. Debnath I., Roundy K.M., Dunn D.M., Weiss R.B., Weis J.J., and Weis J.H. Defining a transcriptional fingerprint of murine splenic B-cell development. Genes Immun. (2008)
9. Engelke M., Engels N., Dittmann K., Stork B., and Wienands J. Ca(2+) signaling in antigen receptor-activated B lymphocytes. Immunol. Rev. 218 (2007) 235-246
10. Fang Y., Xu C., Fu Y.X., Holers V.M., and Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160 (1998) 5273-5279
11. Fujimoto M., Bradney A.P., Poe J.C., Steeber D.A., and Tedder T.F. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11 (1999) 191-200
12. Fujimoto M., Poe J.C., Jansen P.J., Sato S., and Tedder T.F. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162 (1999) 7088-7094
13. Glynne R., Ghandour G., Rayner J., Mack D.H., and Goodnow C.C. B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev. 176 (2000) 216-246
14. Haas K.M., Hasegawa M., Steeber D.A., Poe J.C., Zabel M.D., Bock C.B., Karp D.R., Briles D.E., Weis J.H., and Tedder T.F. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17 (2002) 713-723
15. Hasegawa M., Fujimoto M., Poe J.C., Steeber D.A., Lowell C.A., and Tedder T.F. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. J. Immunol. 167 (2001) 2469-2478
16. Jacobson A.C., and Weis J.H. Comparative functional evolution of human and mouse CR1 and CR2. J. Immunol. 181 (2008) 2953-2959
17. Jacobson A.C., Weis J.J., and Weis J.H. Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner. J. Immunol. 180 (2008) 5057-5066
18. Johanson R.A., Sarau H.M., Foley J.J., and Slemmon J.R. Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II In situ. J. Neurosci. 20 (2000) 2860-2866
19. Kurtz C.B., O'Toole E., Christensen S.M., and Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144 (1990) 3581-3591
20. Lee Y., Haas K.M., Gor D.O., Ding X., Karp D.R., Greenspan N.S., Poe J.C., and Tedder T.F. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J. Immunol. 175 (2005) 8011-8023
21. Luxembourg A.T., and Cooper N.R. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153 (1994) 4448-4457
22. Lyubchenko T., Dal Porto J.M., Holers V.M., and Cambier J.C. Cutting edge: complement (C3d)-linked antigens break B cell anergy. J. Immunol. 179 (2007) 2695-2699
23. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., and Chaplin D.D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3357-3361
24. Nitschke L., Carsetti R., Ocker B., Kohler G., and Lamers M.C. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7 (1997) 133-143
25. Putkey J.A., Kleerekoper Q., Gaertner T.R., and Waxham M.N. A new role for IQ motif proteins in regulating calmodulin function. J. Biol. Chem. 278 (2003) 49667-49670
26. Putkey J.A., Waxham M.N., Gaertner T.R., Brewer K.J., Goldsmith M., Kubota Y., and Kleerekoper Q.K. Acidic/IQ motif regulator of calmodulin. J. Biol. Chem. 283 (2008) 1401-1410
27. Roozendaal R., and Carroll M.C. Complement receptors CD21 and CD35 in humoral immunity. Immunol. Rev. 219 (2007) 157-166
28. Sato S., Jansen P.J., and Tedder T.F. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signalling. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13158-13162
29. Sato S., Tuscano J.M., Inaoki M., and Tedder T.F. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin. Immunol. 10 (1998) 287-297
30. Tedder T.F., Inaoki M., and Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6 (1997) 107-118
31. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., and Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11490-11494
32. Whipple E.C., Shanahan R.S., Ditto A.H., Taylor R.P., and Lindorfer M.A. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. J. Immunol. 173 (2004) 2297-2306
33. Wilson H.A., Greenblatt D., Taylor C.W., Putney J.W., Tsien R.Y., Finkelman F.D., and Chused T.M. The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor. J. Immunol. 138 (1987) 1712-1718